OTC

Strength

4; 15; 10 mg/5mL; mg/5mL; mg/5mL

NDC

68047018616

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

1/6/2011

Pharmacological Classes

Adrenergic alpha1-Agonists
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

-0.0%

3M

+1.1%

6M

+2.4%

1Y

+1.9%

3Y

-3.8%

5Y

+10.2%

All

+40.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.